Home » Topics » Disease categories and therapies » Immune

Immune
RSS

New CB2 agonists and their use in autoimmune diseases, etc.

July 16, 2002

Abiogen and Philogen collaborate on hepatitis C and tetanus vaccines

July 16, 2002

MedImmune receives FluMist complete response letter

July 15, 2002

Kyorin patents new immunosuppressant proteasome inhibitors

July 11, 2002

Large Scale Biology enters collaboration for developing plant-derived vaccines

July 10, 2002

Immune type-selective proteasome inhibitors identified at Kyorin

July 10, 2002

Aventis Pasteur introduces next-generation Daptacel vaccine

July 8, 2002

E.U. approval for Zenapax in pediatric renal transplantation

July 5, 2002

Phase II trials of FluINsure and StreptAvax begin enrollment

July 4, 2002

New STAT6 inhibitors in early development at Tularik

June 25, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...